ABSTRACT The methanol extract and chemical constituents of Lupinus arboreus leaf were investigated for antinociceptive and anti-inflammatory activities. The study was by experimental design. the extract was partitioned to yield hexane, ethylacetate, and methanol fractions. Phytochemical tests were done on the extract and fractions. Acute toxicity test (LD50) was carried out on crude methanol leaf extract (CME). Extract hexane fraction (HEF), ethylacetate fraction (EAF) and methanol fraction (MEF) were subjected to bioactivity guided fractionation using mice tail immersion, hot plate, acetic acid- induced tests and formaldehyde- and, egg albumin-induced rat paw oedema, as activity guide for antinociceptive and anti-inflammatory studies respectively. The active constituents were isolated by bioactivity-guided silica gel column chromatography eluted with gradient mixtures. The isolated active compounds were characterized using a combination of phytochemical analysis, m.p. determination, UV, IR, NMR and GC/MS spectral analyses. The intraperitoneal (i.p) LD50 of the crude methanol extract was 84.85 mg/kg. Phytochemical analysis of the methanol extract indicated the presence of steroids, flavonoids, glycosides, terpenes and saponins. Tannin, resin, reducing sugar and protein were moderately present. The hexane fraction contained steroids and terpenes while ethylacetate fraction contained flavonoids and glycosides. Two active compounds AHF1 and AHF2 were obtained from the hexane fraction while AEF1 was obtained from the ethyl acetate fraction. The AHF1 contained steroids. while AHF2 contained terpenes; AEF1 contained flavonoids. The crude methanol extract (CME) (30 and 60 mg/kg,) i.p produced dose-related resistance against thermal pain and significant (p< 0.01) inhibition of pain. On acetic-induced writhing test CME exhibited a dose- related antinociceptive activity with 71.13 and 47.80 % at 60 and 30 mg/kg respectively. Fractions HEF, and EAF exhibited significant (p < 0.05) pain inhibition of 73 and 64 % respectively while MEF produced 24 percent pain inhibition. AHF1 and AHF2 fractionated from HEF significantly (p< 0.05) exhibited pain inhibition of 75 and 71 % respectively at 30 mg/kg. AEF1 (30 mg/kg) also significantly (p< 0.05) inhibited pain reflex by 71 %. In egg albumin-induced (acute) oedema in rats, CME (30 and 60 mg/kg) produced a dose-related oedema inhibition of 81.10 and 91.50 % respectively at the 4th hour. Similarly, the hexane fraction (HEF) and ethylacetate (EAF) at 60 mg/kg produced a significant (p< 0.05) oedema inhibition of 79 and 40 % respectively at 4th hour. The effect of methanol fraction (MEF) (60 mg/kg) was vi not significant (p> 0.05). The oedema inhibition recorded by HEF and EAF were higher than the inhibition by aspirin (100 mg/kg). The CME (30 and 60 mg/kg) significantly inhibited formaldehyde- induced arthritis, in a dose-related, manner over a period of 4 hours (p< 0.05) (68 and 69 % inhibition respectively). Both HEF and EAF at 60 mg/kg i.p, significantly (p< 0.05) inhibited the oedematous response to formaldehyde-induced arthritis, causing 85.7 and 64.2 % inhibition respectively. The inhibitory effects of the isolates AHF1, AHF2 and AEF1 on egg albumininduced (acute) oedema in rats (78; 72, and 66 % respectively) were significant and better than that of aspirin (100 mg/kg) (46 %). The effect of AHF1, AHF2 and AEF1, (30 mg/kg i.p) on formaldehyde-induced (chronic) oedema in rats were 79 %, 72 % and 65 % respectively. The isolated active compounds were identified as stigmastene 3, 6-dione (AHF1), ursolic acid (AHF 2), tetrahydroxyflavone-3αrhamnoside (AEF1), and ellagic acid (AEF 2). In this study, the extract and fractions of L. arboreus leaves exhibited antinociceptive effect in different models of pain; and anti-inflammatory effects against both acute and chronic models of inflammation. The isolated compounds AHF1, AHF2 and AEF 1 appear to be responsible for the antinociceptive and anti-inflammatory effects. The compound AEF2 identified as ellagic acid, known for its antimicrobial activity, was concomitantly isolated. These compounds were isolated and characterized for the first time from L. arboreus.
CHIKA, S (2022). Pharmacological Assessment of Lupinus Arboreus Sims (Fabaceae) Methanol Extract and Three Active Constituents for Antinociceptive and Anti-Inflammatory Effects. Afribary. Retrieved from https://tracking.afribary.com/works/pharmacological-assessment-of-lupinus-arboreus-sims-fabaceae-methanol-extract-and-three-active-constituents-for-antinociceptive-and-anti-inflammatory-effects-2
CHIKA, SYLVESTER "Pharmacological Assessment of Lupinus Arboreus Sims (Fabaceae) Methanol Extract and Three Active Constituents for Antinociceptive and Anti-Inflammatory Effects" Afribary. Afribary, 18 Oct. 2022, https://tracking.afribary.com/works/pharmacological-assessment-of-lupinus-arboreus-sims-fabaceae-methanol-extract-and-three-active-constituents-for-antinociceptive-and-anti-inflammatory-effects-2. Accessed 24 Nov. 2024.
CHIKA, SYLVESTER . "Pharmacological Assessment of Lupinus Arboreus Sims (Fabaceae) Methanol Extract and Three Active Constituents for Antinociceptive and Anti-Inflammatory Effects". Afribary, Afribary, 18 Oct. 2022. Web. 24 Nov. 2024. < https://tracking.afribary.com/works/pharmacological-assessment-of-lupinus-arboreus-sims-fabaceae-methanol-extract-and-three-active-constituents-for-antinociceptive-and-anti-inflammatory-effects-2 >.
CHIKA, SYLVESTER . "Pharmacological Assessment of Lupinus Arboreus Sims (Fabaceae) Methanol Extract and Three Active Constituents for Antinociceptive and Anti-Inflammatory Effects" Afribary (2022). Accessed November 24, 2024. https://tracking.afribary.com/works/pharmacological-assessment-of-lupinus-arboreus-sims-fabaceae-methanol-extract-and-three-active-constituents-for-antinociceptive-and-anti-inflammatory-effects-2